Diferencia entre revisiones de «Hyperphosphatemia»

Sin resumen de edición
Sin resumen de edición
Línea 1: Línea 1:
==Background==
==Background==
*>4.5mg/dL<ref>Hawley C. Serum phosphate. Nephrology. Apr 2006. 11(S1):S201-5.</ref>
===Major Causes===
===Major Causes===
*Increased phosphate intake (Vitamin D, laxative abuse
*Increased phosphate intake (Vitamin D, laxative abuse
Línea 25: Línea 24:


==Evaluation==
==Evaluation==
*>4.5mg/dL<ref>Hawley C. Serum phosphate. Nephrology. Apr 2006. 11(S1):S201-5.</ref>
===Labs===
===Labs===
Symptoms usually related to associated renal failure, [[hypocalcemia]] or [[hypomagnesemia]]
Symptoms usually related to associated renal failure, [[hypocalcemia]] or [[hypomagnesemia]]
Línea 32: Línea 32:
{{Hyperphosphatemia treatment}}
{{Hyperphosphatemia treatment}}


==References==
==Disposition==
<references/>


==See Also==
==See Also==
*[[Electrolyte Abnormalities (Main)]]
*[[Electrolyte Abnormalities (Main)]]
==References==
<references/>


[[Category:FEN]]
[[Category:FEN]]

Revisión del 10:28 25 oct 2016

Background

Major Causes

Clinical Features

Differential Diagnosis

Evaluation

Labs

Symptoms usually related to associated renal failure, hypocalcemia or hypomagnesemia

  • Metabolic Panel (with calcium, Magnesium, and Phosphorus)

Management

Hyperphosphatemia treatment

  • Treat the underlying cause
  • Restrict calcium phosphate intake
  • IV Normal Saline (if normal renal fx)
  • Acetazolamide (500mg IV q6hr) - if normal renal function
  • Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect
  • Dialysis if refractory

Disposition

See Also

References

  1. Hawley C. Serum phosphate. Nephrology. Apr 2006. 11(S1):S201-5.